National Gaucher Foundation - Gaucher Disease
Slideshow Image 1
Slideshow Image 2
Slideshow Image 3

Shire - Human Genetic Therapies

Other information

Shire's website for patients and physicians
Website provides information relative to VPRIV® for patients and physicians and provides updates on treatment sites as they become available. To assist patients who wish to begin the treatment protocol, Shire has provided a grant to help patients with expenses related to treatment with VPRIV®.


Shire HGT, a business unit of global specialty biopharmaceutical company
Shire plc, is committed to collaborating with academic researchers, health care professionals, and patient associations around the world.

Our shared goal is a deeper understanding of life-altering genetic disorders. Our work together includes the investigation and development of therapeutic approaches in rare genetic diseases.

For more information about Shire, visit our corporate web site at:

OnePath® provides comprehensive support for patients, families and healthcare providers needing assistance with approved Shire HGT products/therapies. Shire Human Genetic Therapies (HGT) is committed to generating awareness of rare genetic diseases, as well as assisting patients, families, and physicians through product support and access programs for approved Shire HGT products. With one toll-free call to 1-866-888-0660, patients, families, and healthcare professionals can get access to a wide range of product support services for approved Shire HGT products.

OnePath® for Patients & Families
OnePath® is the product support center for approved Shire HGT products that can help you with many aspects of your therapy. When you contact OnePath®, you can speak with a case manager who will help address questions you may have about approved Shire HGT products. OnePath® case managers have access to many important resources.

If you are a physician or patient looking for more information about Shire HGT's treatment VPRIV® for Gaucher disease, please contact OnePath® by calling 1-866-888-0660 or OnePath® will direct inquiries to appropriate clinical trial management personnel. is an online resource for patients, families, and health care professionals seeking more information about certain rare diseases and living with rare diseases. The Web site is developed and maintained by Shire Human Genetic Therapies (HGT), a business unit of Shire plc.Brave Community is a dynamic source of information and insights about certain rare diseases including;

Gaucher Disease
Hunter Syndrome
Fabry Disease
and others


Who We Are
Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder, human genetic therapies and gastrointestinal diseases. Shire believes that a carefully selected portfolio of products with a strategically aligned and relatively small-scale sales force will deliver strong results.

Research and Development
Shire, a global specialty biopharmaceutical company, has a strategic R&D focus on attention deficit and hyperactivity disorder (ADHD), gastrointestinal (GI) and human genetic therapies.
Shire Human Genetic Therapies.

Contact information:
300 Shire Way
Lexington, MA 02421 USA
Local Office Receptionist: 617-349-0200
Fax: 888-990-0008
Monday - Friday 8:30AM - 5:00PM ET


For all Shire Customer inquiries, please call OnePath SM at 866-888-0660. Shire Customers may also contact us by email at